These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. HIV/AIDS following sexual assault in Jamaican children and adolescents: a case for HIV post-exposure prophylaxis. Steel-Duncan JC; Pierre R; Evans-Gilbert T; Rodriquez B; Christie CD West Indian Med J; 2004 Oct; 53(5):352-5. PubMed ID: 15675503 [TBL] [Abstract][Full Text] [Related]
23. HIV transmission and sexually transmitted infections. Hay P Clin Med (Lond); 2008 Jun; 8(3):323-6. PubMed ID: 18624048 [No Abstract] [Full Text] [Related]
24. Post-exposure prophylaxis following non-occupational exposure to HIV: risks, uncertainties, and ethics. Mackie NE; Coker RJ Int J STD AIDS; 2000 Jul; 11(7):424-7. PubMed ID: 10919482 [TBL] [Abstract][Full Text] [Related]
25. Recapturing justice in the managed care era. Moreno JD Camb Q Healthc Ethics; 1996; 5(4):493-9. PubMed ID: 8985580 [No Abstract] [Full Text] [Related]
26. [Post-exposure prophylaxis against HIV, do we use our resources appropriately?]. Escudero-Sánchez R; Kurt Meier-de-Taboada CJ; Bartolome-García E; Rodríguez-de-Bethencourt-Sanjuan PM; Losa-García JE Rev Esp Quimioter; 2017 Aug; 30(4):293-296. PubMed ID: 28612589 [TBL] [Abstract][Full Text] [Related]
27. A tale of two-component generalised HIV epidemics. Shelton JD Lancet; 2010 Mar; 375(9719):964-6. PubMed ID: 20304227 [No Abstract] [Full Text] [Related]
28. Condoms and HIV transmission. Johnson AM N Engl J Med; 1994 Aug; 331(6):391-2. PubMed ID: 8028620 [No Abstract] [Full Text] [Related]
29. [Vertical trasmission of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI)]. Casalini C; Signorini L; Beltrame A; Matteelli A; Carosi G Minerva Ginecol; 2001 Jun; 53(3):177-92. PubMed ID: 11395690 [TBL] [Abstract][Full Text] [Related]
30. Risk of contracting HIV. AIDS Patient Care STDS; 2001 May; 15(5):292. PubMed ID: 11530773 [No Abstract] [Full Text] [Related]
32. The ethics of placebo-controlled trials for perinatal transmission of HIV in developing countries. Clark PA J Clin Ethics; 1998; 9(2):156-66. PubMed ID: 9750987 [No Abstract] [Full Text] [Related]
33. CDC: avoid preventive therapy for sexual risk. Centers for Disease Control and Prevention. AIDS Alert; 1996 Jul; 11(7):75-6. PubMed ID: 11363548 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. Pinkerton SD; Holtgrave DR; Bloom FR AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204 [TBL] [Abstract][Full Text] [Related]
35. Post-exposure prophylaxis for sexual exposure to HIV. Pozniak A Curr Opin Infect Dis; 2004 Feb; 17(1):39-40. PubMed ID: 15090888 [No Abstract] [Full Text] [Related]
36. Microbicide data show promise. AIDS Patient Care STDS; 2009 Mar; 23(3):223-4. PubMed ID: 19480060 [No Abstract] [Full Text] [Related]
38. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes. Notario-Pérez F; Ruiz-Caro R; Veiga-Ochoa MD Drug Des Devel Ther; 2017; 11():1767-1787. PubMed ID: 28670111 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic ethics and communities at risk in the presence of potential mutation to resistant strains to HIV antiviral medications. Friedman SR; Wainberg MA; Drucker E AIDS; 1998 Nov; 12(16):2089-93. PubMed ID: 9833849 [No Abstract] [Full Text] [Related]
40. LETTER TO THE EDITOR: A response to Wamai et al. de Camargo KR; Mendonça AL; Perrey C; Giami A Glob Public Health; 2015; 10(10):1252. PubMed ID: 26512626 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]